Psychosomatic functional disorders in pulmonary practice

The relevance of studying psychosomatic disorders in somatic clinical practice (including pulmonary practice) stems from the significant prevalence of these disorders, as well as the difficulties in making a differential diagnosis and choosing the most effective tactics for patient management.

The aim of this review was to analyze the available publications on the problem of psychosomatic functional disorders in pulmonary practice, such as hyperventilation syndrome (HVS), including HVS associated with Severe Acute Respiratory Syndrome-related CoronaVirus 2 (SARS-CoV-2) infection, vocal cord dysfunction, and psychogenic cough. The article discusses clinical features of different variants of functional disorders and accompanying psychopathological symptoms (panic attacks, generalized anxiety, etc.), as well as psychogenic factors of their manifestation and changes in the clinical features over time. The corresponding section briefly summarizes current ideas about approaches to effective treatment of this group of disorders and prevention of their chronification.

Conclusion. The clinical heterogeneity of psychosomatic functional disorders in pulmonological practice has been demonstrated, as have important aspects of the diagnosis and treatment of these disorders.

1. Smulevich A.B., ed. [Lectures on psychosomatics]. Moscow: Meditsinskoe informatsionnoe agentstvo; 2014. Available at: 1. http://psychiatry.ru/siteconst/userfiles/file/doc/518/%D0%9B%D0%B5%D0%BA%D1%86%D0%B8%D0%B8%20%D0%BF%D0%BE%20%D1%81%D0%BE%D0%BC%D0%B0%D1%82%D0%B8%D0%BA%D0%B5,%20%D0%A1%D0%BC%D1%83%D0%BB%D0%B5%D0%B2%D0%B8%D1%87%20%D0%90.%D0%91..pdf (in Russian).

2. Dovzhenko T.V., Bobrov A.E., Krasnov V.N. et al. [Psychiatric care in primary health care: availability and need]. Sotsial’naya i klinicheskaya psikhiatriya. 2016; 26 (1): 50–58. Available at: https://cyberleninka.ru/article/n/psihiatricheskaya-pomosch-v-pervichnom-zvene-zdravoohraneniya-obespechennost-i-potrebnost (in Russian).

3. Romasenko L.V., Makhov V.M., Chichkova N.V. [Functional (psychosomatic) disorders in general medical practice]. Nevrologiya, neiropsikhiatriya, psikhosomatika. 2019; 11 (3): 69–73. DOI: 10.14412/2074-2711-2019-3-69-73 (in Russian).

4. Daragan N.V., Chikina S.Yu. [Hyperventilation syndrome in practical work of a pneumologist: pathogenesis, clinical features, diagnosis]. Pul’monologiya. 2011; (5): 87–96. DOI: 10.18093/0869-0189-2011-0-5-87-96 (in Russian).

5. Connett G.J., Thomas M. Dysfunctional breathing in children and adults with asthma. Front. Pediatr. 2018; 6: 406. DOI: 10.3389/fped.2018.00406.

6. Wilson C. Hyperventilation syndrome: diagnosis and reassurance. J. Paramedic Practice. 2018; 10 (9): 370–375. DOI: 10.12968/jpar.2018.10.9.370.

7. Hurvitz M., Weinberger M. Functional respiratory disorders in children. Pediatr. Clin. North Am. 2021; 68 (1): 223–237. DOI: 10.1016/j.pcl.2020.09.013.

8. Ovcharenko S.I., Syrkin A.L., Drobizhev M.Yu. et al. [Hyperventilation syndrome. Comparison of clinical features and lung function in bronchial asthma, essential arterial hypertension, and panic disorders]. Pul’monologiya. 2004; (4): 16–21. Available at: https://journal.pulmonology.ru/pulm/article/view/2451/1899 (in Russian).

9. Raphael R., Dippenaar E. An out-of-hospital perspective on hyperventilation syndrome. J. Paramedic Pract. 2019; 11 (8): 1–7. DOI: 10.12968/jpar.2019.11.8.CPD1.

10. Bennett A. Hyperventilation syndrome. InnovAiT. 2021; 14 (4): 246–249. DOI: 10.1177/1755738020986820.

11. Boulding R., Stacey R., Niven R., Fowler S.J. Dysfunctional breathing: a review of the literature and proposal for classification. Eur. Respir. Rev. 2016; 25 (141): 287–294. DOI: 10.1183/16000617.00882015.

12. Tolin D.F., Lee E., Levy H.C. et al. Psychophysiological assessment of stress reactivity and recovery in anxiety disorders. J. Anxiety Disord. 2021; 82: 102426. DOI: 10.1016/j.janxdis.2021.102426.

13. Cosci F., Mansueto G. Biological and clinical markers in panic disorder. Psychiatry Investig. 2019; 16 (1): 27–36. DOI: 10.30773/pi.2018.07.26.

14. Cha E.J., Hong S., Park D.H. et al. A network analysis of panic symptoms in relation to depression and anxiety sensitivity in patients with panic disorder. J. Affect Disord. 2022; 308: 134–140. DOI: 10.1016/j.jad.2022.04.062.

15. Okuro R.T., Freire R.C., Zin W.A. et al. Panic disorder respiratory subtype: psychopathology and challenge tests an update. Braz. J. Psychiatry. 2020; 42 (4): 420–430. DOI: 10.1590/1516-4446-2019-0717.

16. Munblit D., Nicholson T., Akrami A. et al. PC-COS project steering committee. A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study. Lancet Respir. Med. 2022; 10 (7): 715–724. DOI: 10.1016/S2213-2600(22)00169-2.

17. Mo X., Jian W., Su Z. et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur. Resp. J. 2020; 55 (6): 2001217. DOI: 10.1183/13993003.01217-2020.

18. Xu J., Xu X., Jiang L. et al. SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis. Respir. Res. 2020; 21 (1): 182. DOI: 10.1186/s12931-020-01445-6.

19. Leshchenko I.V., Glushkova T.V. [Development of fibrosis and impairment of lung function in patients with a new coronavirus disease]. Pul’monologiya. 2021; 31 (5): 653–662. DOI: 10.18093/0869-01892021-31-5-653-662 (in Russian).

20. Madi W., Fehri S.M., Sellami R. et al. Incidence of dyspnea and hyperventilation syndrome after COVID-19. Eur. Respir. J. 2022; 60 (Suppl. 66): 1889. DOI: 10.1183/13993003.congress-2022.1889.

21. Taverne J., Salvator H., Leboulch C. et al. High incidence of hyperventilation syndrome after COVID-19. J. Thorac. Dis. 2021; 13 (6): 3918–3922. DOI: 10.21037/jtd-20-2753.

22. Dutheil F., Mondillon L., Navel V. PTSD as the second tsunami of the SARS-Cov-2 pandemic. Psychol. Med. 2021; 51 (10): 1773–1774. DOI: 10.1017/S0033291720001336.

23. Szcześniak D., Gładka A., Misiak B. et al. The SARS-CoV-2 and mental health: From biological mechanisms to social consequences. Prog. Neuropsychopharmacol Biol. Psychiatry. 2021; 104: 110046. DOI: 10.1016/j.pnpbp.2020.110046.

24. Allado E., Poussel M., Hamroun A. et al. Is there a Relationship between hyperventilation syndrome and history of acute SARS-CoV-2 infection? A cross-sectional study. Healthcare (Basel). 2022; 10 (11): 2154. DOI: 10.3390/healthcare10112154.

25. Mazza M.G., De Lorenzo R., Conte C. et al. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav. Immun. 2020; 89: 594–600. DOI: 10.1016/j.bbi.2020.07.037.

26. Glotov S.I., Bhar F.M., Ponomareva I.B. et al. [Difficulties in differential diagnosis of vocal cord dysfunction and asthma]. Pul’monologiya. 2022; 32 (4): 599–607. DOI: 10.18093/0869-0189-2022-32-4-599-607 (in Russian).

27. Brodskaya O.N. [Vocal cord dysfunction: concepts of pathogenesis and differential diagnosis with bronchial asthma]. Astma i allergiya. 2015; (2): 32–35. Available at: https://cyberleninka.ru/article/n/disfunktsiya-golosovyh-svyazok-kontseptsii-patogeneza-i-differentsialnyy-diagnoz-s-bronhialnoy-astmoy (in Russian).

28. Hseu A., Sandler M., Ericson D. et al. Paradoxical vocal fold motion in children presenting with exercise induced dyspnea. Int. J. Pediatr. Otorhinolaryngol. 2016; 90: 165–169. DOI: 10.1016/j.ijporl.2016.09.007.

29. Benninger C., Parsons J.P., Mastronarde J.G. Vocal cord dysfunction and asthma. Curr. Opin. Pulm. Med. 2011; 17 (1): 45–49. DOI: 10.1097/MCP.0b013e32834130ee.

30. Kenn K., Balkissoon R. Vocal cord dysfunction: what do we know? Eur. Respir. J. 2011; 37 (1): 194–200. DOI: 10.1183/09031936.00192809.

31. Low K., Lau K.K., Holmes P. et al. Abnormal vocal cord function in difficult-to-treat asthma. Am. J. Respir. Crit. Care Med. 2011; 184 (1): 50–56. DOI: 10.1164/rccm.2010101604OC.

32. Weinberger M., Lockshin B. When is cough functional, and how should it be treated? Breathe (Sheff.). 2017; 13 (1): 22–30. DOI: 10.1183/20734735.015216.

33. Orlova, N.V. [Chronic cough: differential diagnosis and treatment]. Meditsinskiy sovet. 2020; (17): 124–131. DOI: 10.21518/2079-701X-2020-17-124-131 (in Russian).

34. Lai K., Peng W., Zhan W. et al. Clinical characteristics in adult patients with somatic cough syndrome. Ther. Adv. Respir. Dis. 2022; 16: 17534666221092993. DOI: 10.1177/17534666221092993.

35. Orengul A.C., Ertaş E., Ustabas Kahraman F. et al. Psychiatric comorbidity in children with psychogenic and functional breathing disorders. Pediatr. Pulmonol. 2020; 55 (2): 462–467. DOI: 10.1002/ppul.24565.

36. Udaltsova E.V., Melnikova I.M., Mizernitski Yu.L., Grigorieva E.A. [Clinical aspects of protracted and chronic tussis of the psychogenic genesis in children]. Ural’skiy meditsinskiy zhurnal. 2017; 5 (149): 40–44. Available at: https://www.elibrary.ru/item.asp?id=29381367 (in Russian).

37. Sokolova L.P., Fedin A.I., Chernyaev S.A., Borisova Yu. V. [Autonomic disorders in COVID-19: the use of psychotropic therapy to prevent post-COVID psychosomatic complications]. Lechebnoe delo. 2021 (3): 107–112. DOI: 10.24412/2071-5315-2021-12365 (in Russian).

38. Neznanov N.G., Samushiya M.A., Mazo G.E. et al. [Algorithms for the diagnosis and treatment of mental disorders recorded during the COVID-19 pandemic: a study guide]. Moscow; 2021. Available at: https://docacademy.ru/wp-content/uploads/2021/11/algoritmy-diagnostiki-psihicheskih-rasstrojstv-pri-covid-19.pdf (in Russian).

39. Bhattacharyya R., Gozi A., Sen A. Management of psychiatric disorders in patients with respiratory diseases. Indian J. Psychiatry. 2022; 64 (Suppl. 2): S366–378. DOI: 10.4103/indianjpsychiatry.indianjpsychiatry_25_22.

40. Almis B.H. An interesting model for functional neurological disorders: integrative approach to psychogenic dysphonia. Psikiyatride Guncel Yaklasimlar. 2022; 14 (3): 353–357. DOI: 10.18863/pgy.1018579.